Marit Anderson

Director for gammaCore (nVNS) therapy.

FDA Breakthrough Designation for Treatment of PTSD
gammaCore Reduces Symptoms of Acute Withdrawal in Patients with Opioid Use Disorder
gammaCore Improves Neurobehavioral Outcomes in a Model of TBI

View on mobile